hemantane

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
02420012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Activity of hemantane, an amino adamantane derivative, exhibiting the properties of lowaffinity non-competitive NMDA receptor… (More)
Is this relevant?
2016
2016
The efficacy of some aminoadamantane derivatives used as neurodegeneration treatments is due to their ability to block NMDA… (More)
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 4
Is this relevant?
2015
2015
Hemantane demonstrated a pronounced antiparkinsonian activity in the model of hemiparkinsonian syndrome provoked in rats by… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
A large body of literature supports the idea that inflammation exacerbates neurodegenerative pathology. This idea is also… (More)
Is this relevant?
2013
2013
A single intraperitoneal injection of MPTP neurotoxin (30 mg/kg) in C57BL/6 mice causes desynchronization of EEG with a decrease… (More)
Is this relevant?
2011
2011
Chronic administration of levodopa and benserazide (10 and 15 mg/kg, respectively) cause the development of dyskinesia in rats… (More)
Is this relevant?
2011
2011
The pharmacokinetics ofhemantane after administration in different ways has been studied in rats. It is established that… (More)
Is this relevant?
2011
2011
The effects of anti-parkinsonian drug hemantane [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.) and/or antibiotic drug… (More)
Is this relevant?
2008
2008
The effect of the antiparkinsonian drug hemantane on various subtypes of dopamine receptors in the striatum of Wistar rats have… (More)
Is this relevant?